newslung cancer screeningnicotine replacement therapy
Optimizing Smoking Cessation Interventions in Lung Cancer Screening: Insights from the CASTL Trial
By MedXY|Jul 11, 2026
The CASTL trial evaluated efficient combinations of tobacco cessation interventions for smokers undergoing lung cancer screening, identifying loss-framed messaging with nicotine replacement therapy as the most cost-effective strategy.
